In 2023, the hospital discharges for Crohn's Disease and Ulcerative Colitis cases in France stood at 13.07 thousand. Forecasted data indicates a declining trend from 2024 through 2028, with a year-on-year reduction in hospital discharges ranging from approximately 3% to 2.6%. Specifically, the compound annual growth rate (CAGR) over this period suggests a consistent average decrease of 3.65% annually through 2028. This trend reflects possible improvements in disease management or shifts in healthcare delivery models that reduce hospitalizations.

Future trends to watch for include:

Advancements in treatment protocols or drug therapies that might further reduce hospital stays.
An increase in outpatient care services or telemedicine applications that might impact hospitalization rates.
Potential variations linked to demographic changes or policy shifts in healthcare access and delivery in France.